Pharmasset (VRUS) Posts Weaker Results for FY11; Loss Widens
Tweet
Share
E-mailGet Alerts VRUS Hot Sheet
Price: $0.00 --0%
Financial Fact:
Net loss per share: basic and diluted: -0.6
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Net loss per share: basic and diluted: -0.6
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Pharmasset, Inc. (Nasdaq: VRUS) reports FY11 loss of $1.25 per share, versus ($1.07) reported for the same period a year ago. Revenue for the year was $897 thousand, compared to $1.02 million in FY10.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- XP Inc. (XP) Tops Q2 EPS by 8c
- INVO Fertility (IVF) Tops Q2 EPS by 105c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
